Article
Tropisetron modulation of the glycine receptor: femtomolar potentiation and a molecular determinant of inhibition.
Journal of neurochemistry - 1 Feb 2007
Yang Zhe, Ney Agnieszka, Cromer Brett A, Ng Hooi-Ling, Parker Michael W, Lynch Joseph W
Abstract excerpt
The 5-hydroxytryptamine type-3 receptor antagonist tropisetron is in clinical use as an anti-emetic drug. This compound also exerts both potentiating and inhibitory effects on the glycine receptor chloride channel. The inhibitory effects occur at micromolar concentrations, whereas the potentiatin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
